Latest Innovation News

Chimeric Therapeutics has received a $4.5 million R&D tax incentive refund from the Australian Government, underscoring its ongoing investment in innovative cancer cell therapies.

Wide Open Agriculture has received a $586,624 tax rebate for its overseas research activities in Germany, supporting the commercialisation of its proprietary lupin protein products.

OpenLearning has secured a landmark three-year SaaS and referral agreement with Field Ready, a leading African education-to-employment provider, marking a significant expansion into emerging markets with its AI-powered LMS.

Cynata Therapeutics has completed the final patient visit in its Phase 3 trial for CYP-004, targeting knee osteoarthritis, with results expected in mid-2026. This milestone advances hopes for a disease-modifying therapy in a market desperate for new options.

Integrated Research Limited reported a modest revenue dip and significant profit declines in FY25 as it pivots to a product-led growth strategy focused on AI-powered observability solutions and hybrid pricing models.

ClearVue Technologies has secured an A$881k Australian Government R&D rebate and used part of it to retire a A$409k loan, strengthening its financial position as it advances its solar glass technology.

DroneShield Limited reaffirms strong business fundamentals with record revenues in 2025, while addressing recent media reports and initiating an independent governance review.

IRIS Metals has partnered with Rock Zero to pioneer a low-emission lithium refining process in the U.S., aiming to secure a domestic supply chain with breakthrough technology.

Icetana reveals its FY26 strategy focused on transforming Security Operations Centers with predictive, explainable, and autonomous AI, aiming to enhance threat detection and operational efficiency.

Altech Batteries has secured a strategic collaboration with a leading global battery manufacturer to evaluate its breakthrough Silumina Anodes™ silicon-enhanced technology, marking a significant step toward commercialisation.

Gentrack delivered solid FY25 results with 8% revenue growth and a doubling of net profit, driven by strong recurring revenues and strategic investments. The company is poised for accelerated expansion in FY26, backed by a maturing pipeline and new technology deployments.

Gentrack Group reported robust FY25 results with an 8% revenue rise to NZ$230.2m and a 119% jump in net profit, driven by strong growth in utilities and airports segments alongside strategic investments in its new cloud platform and global expansion.